Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression
- PMID: 21135325
- PMCID: PMC3311113
- DOI: 10.1001/archgenpsychiatry.2010.168
Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression
Abstract
Context: Mindfulness-based cognitive therapy (MBCT) is a group-based psychosocial intervention designed to enhance self-management of prodromal symptoms associated with depressive relapse.
Objective: To compare rates of relapse in depressed patients in remission receiving MBCT against maintenance antidepressant pharmacotherapy, the current standard of care.
Design: Patients who met remission criteria after 8 months of algorithm-informed antidepressant treatment were randomized to receive maintenance antidepressant medication, MBCT, or placebo and were followed up for 18 months.
Setting: Outpatient clinics at the Centre for Addiction and Mental Health, Toronto, Ontario, Canada, and St Joseph's Healthcare, Hamilton, Ontario.
Participants: One hundred sixty patients aged 18 to 65 years meeting DSM-IV criteria for major depressive disorder with a minimum of 2 past episodes. Of these, 84 achieved remission (52.5%) and were assigned to 1 of the 3 study conditions.
Interventions: Patients in remission discontinued their antidepressants and attended 8 weekly group sessions of MBCT, continued taking their therapeutic dose of antidepressant medication, or discontinued active medication and were switched to placebo.
Main outcome measure: Relapse was defined as a return, for at least 2 weeks, of symptoms sufficient to meet the criteria for major depression on module A of the Structured Clinical Interview for DSM-IV.
Results: Intention-to-treat analyses showed a significant interaction between the quality of acute-phase remission and subsequent prevention of relapse in randomized patients (P = .03). Among unstable remitters (1 or more Hamilton Rating Scale for Depression score >7 during remission), patients in both MBCT and maintenance treatment showed a 73% decrease in hazard compared with placebo (P = .03), whereas for stable remitters (all Hamilton Rating Scale for Depression scores ≤7 during remission) there were no group differences in survival.
Conclusions: For depressed patients achieving stable or unstable clinical remission, MBCT offers protection against relapse/recurrence on a par with that of maintenance antidepressant pharmacotherapy. Our data also highlight the importance of maintaining at least 1 long-term active treatment in unstable remitters.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3311113/bin/nihms361609f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3311113/bin/nihms361609f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3311113/bin/nihms361609f3.gif)
Similar articles
-
The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis.BMC Psychiatry. 2018 Feb 23;18(1):50. doi: 10.1186/s12888-018-1610-5. BMC Psychiatry. 2018. PMID: 29475431 Free PMC article. Review.
-
Prevention of relapse/recurrence in major depressive disorder with either mindfulness-based cognitive therapy or cognitive therapy.J Consult Clin Psychol. 2018 Feb;86(2):200-204. doi: 10.1037/ccp0000266. Epub 2017 Dec 21. J Consult Clin Psychol. 2018. PMID: 29265831 Clinical Trial.
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
-
The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).Health Technol Assess. 2015 Sep;19(73):1-124. doi: 10.3310/hta19730. Health Technol Assess. 2015. PMID: 26379122 Free PMC article. Clinical Trial.
-
Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.Lancet. 2015 Jul 4;386(9988):63-73. doi: 10.1016/S0140-6736(14)62222-4. Epub 2015 Apr 20. Lancet. 2015. PMID: 25907157 Clinical Trial.
Cited by
-
Identifying relapse predictors in individual participant data with decision trees.BMC Psychiatry. 2023 Nov 13;23(1):835. doi: 10.1186/s12888-023-05214-9. BMC Psychiatry. 2023. PMID: 37957596 Free PMC article.
-
Supporting antidepressant discontinuation using mindfulness plus monitoring versus monitoring alone: A cluster randomized trial in general practice.PLoS One. 2023 Sep 5;18(9):e0290965. doi: 10.1371/journal.pone.0290965. eCollection 2023. PLoS One. 2023. PMID: 37669281 Free PMC article. Clinical Trial.
-
An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist.Int J Clin Pharm. 2023 Oct;45(5):1074-1087. doi: 10.1007/s11096-023-01602-z. Epub 2023 Jun 3. Int J Clin Pharm. 2023. PMID: 37269440 Free PMC article.
-
A randomized controlled trial of a 14-day mindfulness ecological momentary intervention (MEMI) for generalized anxiety disorder.Eur Psychiatry. 2023 Jan 16;66(1):e12. doi: 10.1192/j.eurpsy.2023.2. Eur Psychiatry. 2023. PMID: 36645098 Free PMC article. Clinical Trial.
-
Protocol for a randomized controlled trial of mindfulness-based stress reduction to improve attentional control in older adults (HealthyAgers trial).BMC Geriatr. 2022 Aug 13;22(1):666. doi: 10.1186/s12877-022-03334-7. BMC Geriatr. 2022. PMID: 35964000 Free PMC article.
References
-
- Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, Endicott J, Coryell W, Kunovac JL, Mueller TI, Rice JP, Keller MB. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry. 2000;57:375–380. - PubMed
-
- Practice guideline for the treatment of patients with major depressive disorder (revision) Am J Psychiatry. 2000;157(4 suppl):1–45. - PubMed
-
- ten Doesschate MC, Bockting CL, Schene AH. Adherence to continuation and maintenance antidepressant use in recurrent depression. J Affect Disord. 2009;115:167–170. - PubMed
-
- Simon GE, Von Korff M, Rutter CM, Peterson DA. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry. 2001;58:395–401. - PubMed
-
- Fava GA, Ruini C, Rafanelli C. Sequential treatment of mood and anxiety disorders. J Clin Psychiatry. 2005;66:1392–1400. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous